Cogent Biosciences, Inc. (COGT): debt financing — Cogent Biosciences signs 7yr10mo lease for new Waltham HQ at $32/sq ft

Cogent Biosciences, Inc.

Leases 31,518 sq ft at 180 Third Avenue, Waltham, MA as new corporate headquarters, replacing existing HQ.
Term of 7 years 10 months starting expected May 2026; initial rent $32/sq ft with $1/sq ft annual increases.
Rent abatement for first 5 months; security deposit of ~$336,000 via letter of credit.
One option to extend lease for an additional 5 years.
Landlord performing turnkey buildout; no material tenant improvement costs for Cogent.

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

Cogent Biosciences, Inc. incurred lease obligation with BP THIRD AVENUE LLC maturing seven (7) years and ten (10) months from the Commencement Date.

Instrument: lease obligation
Counterparty: BP THIRD AVENUE LLC
Maturity: seven (7) years and ten (10) months from the Commencement Date
Event: incurrence

Exact text from the filing

On September 5, 2025, Cogent Biosciences, Inc. (“Cogent”) and BP THIRD AVENUE LLC, an affiliate of Boston Properties (the “Landlord”), entered into a lease agreement (the “Lease”)

View on SEC.gov

Browse all debt financings →

Cogent Biosciences, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-25-201353

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.